BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 1699801)

  • 1. MAP 30: a new inhibitor of HIV-1 infection and replication.
    Lee-Huang S; Huang PL; Nara PL; Chen HC; Kung HF; Huang P; Huang HI; Huang PL
    FEBS Lett; 1990 Oct; 272(1-2):12-8. PubMed ID: 1699801
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-HIV and anti-tumor activities of recombinant MAP30 from bitter melon.
    Lee-Huang S; Huang PL; Chen HC; Huang PL; Bourinbaiar A; Huang HI; Kung HF
    Gene; 1995 Aug; 161(2):151-6. PubMed ID: 7665070
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of HIV infection by baicalin--a flavonoid compound purified from Chinese herbal medicine.
    Li BQ; Fu T; Yan YD; Baylor NW; Ruscetti FW; Kung HF
    Cell Mol Biol Res; 1993; 39(2):119-24. PubMed ID: 7693133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human immunodeficiency virus type 1 (HIV-1) inhibition, DNA-binding, RNA-binding, and ribosome inactivation activities in the N-terminal segments of the plant anti-HIV protein GAP31.
    Lee-Huang S; Kung HF; Huang PL; Bourinbaiar AS; Morell JL; Brown JH; Huang PL; Tsai WP; Chen AY; Huang HI
    Proc Natl Acad Sci U S A; 1994 Dec; 91(25):12208-12. PubMed ID: 7527556
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TAP 29: an anti-human immunodeficiency virus protein from Trichosanthes kirilowii that is nontoxic to intact cells.
    Lee-Huang S; Huang PL; Kung HF; Li BQ; Huang PL; Huang P; Huang HI; Chen HC
    Proc Natl Acad Sci U S A; 1991 Aug; 88(15):6570-4. PubMed ID: 1713684
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of HIV replication by naphthalenemonosulfonic acid derivatives and a bis naphthalenedisulfonic acid compound.
    Mohan P; Singh R; Wepsiec J; Gonzalez I; Sun DK; Sarin PS
    Life Sci; 1990; 47(12):993-9. PubMed ID: 2122146
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A synthetic HIV-1 protease inhibitor with antiviral activity arrests HIV-like particle maturation.
    Dis Markers; 1990; 8(3):162-3. PubMed ID: 2125537
    [No Abstract]   [Full Text] [Related]  

  • 8. Modification of human immunodeficiency viral replication by pine cone extracts.
    Lai PK; Donovan J; Takayama H; Sakagami H; Tanaka A; Konno K; Nonoyama M
    AIDS Res Hum Retroviruses; 1990 Feb; 6(2):205-17. PubMed ID: 1691654
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alpha-momorcharin inhibits HIV-1 replication in acutely but not chronically infected T-lymphocytes.
    Zheng YT; Ben KL; Jin SW
    Zhongguo Yao Li Xue Bao; 1999 Mar; 20(3):239-43. PubMed ID: 10452099
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of the integrase of human immunodeficiency virus (HIV) type 1 by anti-HIV plant proteins MAP30 and GAP31.
    Lee-Huang S; Huang PL; Huang PL; Bourinbaiar AS; Chen HC; Kung HF
    Proc Natl Acad Sci U S A; 1995 Sep; 92(19):8818-22. PubMed ID: 7568024
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro assays show a dissociation of reverse transcriptase activity and core antigen (p24) production in two HIV-1 isolates from a patient receiving long-term treatment with zidovudine (ZDV).
    Masquelier B; Combeau T; Poveda JD; Delord B; Pellegrin JL; Sallafranque-Andreola ML; Tarrago-Litvak L; Fleury HJ
    J Acquir Immune Defic Syndr (1988); 1991; 4(5):499-505. PubMed ID: 1707962
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of HIV-1 replication by balsamin, a ribosome inactivating protein of Momordica balsamina.
    Kaur I; Puri M; Ahmed Z; Blanchet FP; Mangeat B; Piguet V
    PLoS One; 2013; 8(9):e73780. PubMed ID: 24040067
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of a key target sequence to block human immunodeficiency virus type 1 replication within the gag-pol transframe domain.
    Sei S; Yang QE; O'Neill D; Yoshimura K; Nagashima K; Mitsuya H
    J Virol; 2000 May; 74(10):4621-33. PubMed ID: 10775598
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of HIV-1 replication in H9 cells by nystatin-A compared with other antiviral agents.
    Selvam MP; Blay RA; Geyer S; Buck SM; Pollock L; Mayner RE; Epstein JS
    AIDS Res Hum Retroviruses; 1993 May; 9(5):475-81. PubMed ID: 7686387
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiviral action of oligodeoxyguanylic acids against human immunodeficiency virus type 1.
    Fujihashi T; Sakata T; Kaji A; Kaji H
    AIDS Res Hum Retroviruses; 1995 Apr; 11(4):461-71. PubMed ID: 7543270
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preliminary evidence for inhibitory effect of glycyrrhizin on HIV replication in patients with AIDS.
    Hattori T; Ikematsu S; Koito A; Matsushita S; Maeda Y; Hada M; Fujimaki M; Takatsuki K
    Antiviral Res; 1989; 11(5-6):255-61. PubMed ID: 2572198
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Curdlan sulfate and HIV-1. I. In vitro inhibitory effects of curdlan sulfate on HIV-1 infection.
    Aoki T; Kaneko Y; Stefanski MS; Nguyen T; Ting RC
    AIDS Res Hum Retroviruses; 1991 Apr; 7(4):409-15. PubMed ID: 1676899
    [TBL] [Abstract][Full Text] [Related]  

  • 18. (K15R M52E) aprotinin is a weak Kunitz-type inhibitor of HIV-1 replication in H9 cells.
    Auerswald EA; Schubert A; Dolinar M; Gürtler L; Deinhardt F
    Biomed Biochim Acta; 1991; 50(4-6):697-700. PubMed ID: 1724906
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design and synthesis of HIV protease inhibitors. Variations of the carboxy terminus of the HIV protease inhibitor L-682,679.
    deSolms SJ; Giuliani EA; Guare JP; Vacca JP; Sanders WM; Graham SL; Wiggins JM; Darke PL; Sigal IS; Zugay JA
    J Med Chem; 1991 Sep; 34(9):2852-7. PubMed ID: 1910089
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nuclear localization signal of HIV-1 as a novel target for therapeutic intervention.
    Dubrovsky L; Ulrich P; Nuovo GJ; Manogue KR; Cerami A; Bukrinsky M
    Mol Med; 1995 Jan; 1(2):217-30. PubMed ID: 8529100
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.